aHUS Alliance – Press Kit
…an aHUS alliance Press Kit. The aHUS Alliance, a global affiliation of patient organizations and aHUS advocates around the world, is dedicated to sharing information and resources that foster…
aHUS Press Kit
Atypical HUS: PRESS KIT aHUS Info & Resources Patients sharing their rare disease journey help bring new levels of understanding to researchers, industry, and the general public….
aHUS Press Kit
Atypical HUS: PRESS KIT aHUS Info & Resources Patients sharing their rare disease journey help bring new levels of understanding to researchers, industry, and the general public….
OMS721: Omeros Research Collaboration with University of Cambridge
…Us Atypical HUS version 1.0 aHUS Press Kit – Fact Sheets, Graphics, White Papers, aHUS Awareness Day (24 Sept campaigns) & More Omeros –…
aHUS Awareness Day- Images from the aHUS Alliance
…below to our aHUS Alliance Press Kit aHUS Alliance Press Kit and in our INFO CENTRE Resources for aHUS Day & Rare Disease Day …
Info Centre
…the media. Featured below is a collection of assets which include downloadable documents, resource links, or other aHUS information. We welcome you to browse our aHUS Alliance Press Kit. If…
Atypical HUS Key Facts & Info – 2020 Sept 2021
… Research & Publications Resources Press Kit Videos SHUa (Spanish) SHUa (French) aHUS Awareness & Rare Disease Day Atypical HUS: Key Facts & Info 2020 – Sept…
Generium’s Elizaria: First Biosimilar to Eculizumab
…40 nations. The announcement of biosimilar to eculizumab came in an April press release from Selexis, a Swiss company that also has a North American office in California, in partnership…
Atypical HUS Therapeutic Drug Pipeline in 2018
…in complement research. A June 2017 press release by Bioverativ noted their acquisition of True North Therapeutics, to deepen and develop this aspect of Bioverativ’s innovation in rare blood diseases….
Advancements in mRNA – an approach to COVID-19 Vaccines
…from this 9 Nov 2020 press release were as follows. In a study population of over 43,000 people, the Pfizer/BioNTech press release noted their vaccine was 90% effective in preventing…
